{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:43:36Z","timestamp":1777866216303,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009420","name":"Varsinais-Suomen Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009420","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["277535"],"award-info":[{"award-number":["277535"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["140251"],"award-info":[{"award-number":["140251"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["123571"],"award-info":[{"award-number":["123571"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005609","name":"Turun Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011797","name":"Turun Yliopistollinen Keskussairaala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008019","name":"\u00c5bo Akademi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.026","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T08:26:05Z","timestamp":1556007965000},"page":"2935-2941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age"],"prefix":"10.1016","volume":"37","author":[{"given":"Sinikka","family":"Karppinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Toivonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linnea","family":"Schuez-Havupalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Teros-Jaakkola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Waris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Auranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arto A.","family":"Palmu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ville","family":"Peltola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2019.04.026_b0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"issue":"9862","key":"10.1016\/j.vaccine.2019.04.026_b0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1473-3099(13)70338-4","article-title":"Effect of pneumococcal haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3\u20134 trial","volume":"14","author":"Palmu","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"9568","key":"10.1016\/j.vaccine.2019.04.026_b0020","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.026_b0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0030","doi-asserted-by":"crossref","first-page":"e0172690","DOI":"10.1371\/journal.pone.0172690","article-title":"Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in finnish children in a nation-wide population-based study","volume":"12","author":"Palmu","year":"2017","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.026_b0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00006454-200110000-00008","article-title":"Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees","volume":"20","author":"Dagan","year":"2001","journal-title":"Pediatr Infect Dis J."},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.026_b0040","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/INF.0000000000000899","article-title":"Decreased incidence of respiratory infections in children after vaccination with ten-valent pneumococcal vaccine","volume":"34","author":"Sigurdsson","year":"2015","journal-title":"Pediatr Infect Dis J."},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jpids\/piw010","article-title":"Effectiveness of the 10-valent pneumococcal nontypeable haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-A double-blind randomized clinical trial in finland","volume":"5","author":"Vesikari","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.026_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1750-5","article-title":"Udden F, Resman F, Riesbeck K. Reduction of streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a swedish county","volume":"16","author":"Littorin","year":"2016","journal-title":"BMC Infect Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.026_b0055","doi-asserted-by":"crossref","first-page":"e0152481","DOI":"10.1371\/journal.pone.0152481","article-title":"Does viral co-infection influence the severity of acute respiratory infection in children?","volume":"11","author":"Cebey-Lopez","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.026_b0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/381547","article-title":"Nasopharyngeal carriage of streptococcus pneumoniae by adults and children in community and family settings","volume":"38","author":"Regev-Yochay","year":"2004","journal-title":"Clin Infect Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.026_b0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/322048","article-title":"Nasopharyngeal carriage of streptococcus pneumoniae in finnish children younger than 2 years old","volume":"184","author":"Syrjanen","year":"2001","journal-title":"J Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jpids\/pit025","article-title":"Effects of rhinovirus infection on nasopharyngeal bacterial colonization in infants with wild or variant types of mannose-binding lectin and toll-like receptors 3 and 4","volume":"2","author":"Karppinen","year":"2013","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"9","key":"10.1016\/j.vaccine.2019.04.026_b0075","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1164\/rccm.201702-0357OC","article-title":"Acquisition and transmission of streptococcus pneumoniae is facilitated during rhinovirus infection in families with children","volume":"196","author":"Karppinen","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: The key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.026_b0085","doi-asserted-by":"crossref","first-page":"e20170001","DOI":"10.1542\/peds.2017-0001","article-title":"Immunization, antibiotic use, and pneumococcal colonization over a 15-year period","volume":"140","author":"Lee","year":"2017","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.026_b0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/528685","article-title":"Viral upper respiratory tract infection and otitis media complication in young children","volume":"46","author":"Chonmaitree","year":"2008","journal-title":"Clin Infect Dis."},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.026_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The underrecognized burden of influenza in young children","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.026_b0100","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/424527","article-title":"Burden of influenza in children in the community","volume":"190","author":"Heikkinen","year":"2004","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.026_b0105","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/IAI.00422-16","article-title":"Influenza A virus infection predisposes hosts to secondary infection with different streptococcus pneumoniae serotypes with similar outcome but serotype-specific manifestation","volume":"84","author":"Sharma-Chawla","year":"2016","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.026_b0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3851\/IMP1730","article-title":"Preventing and treating secondary bacterial infections with antiviral agents","volume":"16","author":"McCullers","year":"2011","journal-title":"Antivir Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/341462","article-title":"Lethal synergism between influenza virus and streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor","volume":"186","author":"McCullers","year":"2002","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.026_b0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/thx.2007.081752","article-title":"Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages","volume":"63","author":"Oliver","year":"2008","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.026_b0125","doi-asserted-by":"crossref","first-page":"e1003057","DOI":"10.1371\/journal.ppat.1003057","article-title":"Viral and bacterial interactions in the upper respiratory tract","volume":"9","author":"Bosch","year":"2013","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.026_b0130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1086\/379833","article-title":"Effects of rhinovirus infection on the adherence of streptococcus pneumoniae to cultured human airway epithelial cells","volume":"188","author":"Ishizuka","year":"2003","journal-title":"J Infect Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.026_b0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1164\/rccm.201311-2110OC","article-title":"Respiratory syncytial virus increases the virulence of streptococcus pneumoniae by binding to penicillin binding protein 1a. a new paradigm in respiratory infection","volume":"190","author":"Smith","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.026_b0140","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/infdis\/jir467","article-title":"Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection","volume":"204","author":"Goulding","year":"2011","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.026_b0145","doi-asserted-by":"crossref","first-page":"e1001049","DOI":"10.1371\/journal.ppat.1001049","article-title":"The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation","volume":"6","author":"Nguyen","year":"2010","journal-title":"PLoS Pathog"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.026_b0150","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1469-0691.2011.03480.x","article-title":"Streptococcus pneumoniae exposure is associated with human metapneumovirus seroconversion and increased susceptibility to in vitro HMPV infection","volume":"17","author":"Verkaik","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.55.3.445","article-title":"The association of pneumococci, hemophilus influenzae, and streptococcus hemolyticus with coryza, pharyngitis, and sinusitis in man","volume":"55","author":"Webster","year":"1932","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.026_b0160","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/infdis\/jiu326","article-title":"High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia","volume":"210","author":"Wolter","year":"2014","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.026_b0165","doi-asserted-by":"crossref","first-page":"e00255","DOI":"10.1128\/mBio.00255-12","article-title":"Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of streptococcus pneumoniae","volume":"3","author":"Short","year":"2012","journal-title":"MBio"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.026_b0170","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3201\/eid2211.160902","article-title":"Nasopharyngeal pneumococcal density and evolution of acute respiratory illnesses in young children, peru, 2009\u20132011","volume":"22","author":"Fan","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.026_b0175","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jaci.2014.02.030","article-title":"Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations","volume":"133","author":"Kloepfer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.026_b0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10096-010-1075-z","article-title":"Nasopharyngeal bacterial colonization during the first wheezing episode is associated with longer duration of hospitalization and higher risk of relapse in young children","volume":"30","author":"Jartti","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.026_b0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/infdis\/132.1.62","article-title":"Spread of streptococcus pneumoniae in families. II. relation of transfer of S. pneumoniae to incidence of colds and serum antibody","volume":"132","author":"Gwaltney","year":"1975","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.026_b0190","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/INF.0b013e318208ee82","article-title":"Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children","volume":"30","author":"Peltola","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.026_b0195","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1096\/fj.09-146779","article-title":"Influenza A virus facilitates streptococcus pneumoniae transmission and disease","volume":"24","author":"Diavatopoulos","year":"2010","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0200","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1469-0691.2011.03603.x","article-title":"Viruses and bacteria in sputum samples of children with community-acquired pneumonia","volume":"18","author":"Honkinen","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"McCullers","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.026_b0210","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm1077","article-title":"Vaccine Trialist Group. a role for streptococcus pneumoniae in virus-associated pneumonia","volume":"10","author":"Madhi","year":"2004","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0215","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1086\/525542","article-title":"Rhinovirus transmission within families with children: Incidence of symptomatic and asymptomatic infections","volume":"197","author":"Peltola","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.026_b0220","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcv.2013.06.002","article-title":"Comparison of sampling methods for the detection of human rhinovirus RNA","volume":"58","author":"Waris","year":"2013","journal-title":"J Clin Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.026_b0225","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1097\/INF.0000000000001304","article-title":"Burden of recurrent respiratory tract infections in children: A prospective cohort study","volume":"35","author":"Toivonen","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.026_b0230","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1309","article-title":"Rhinovirus infections in the first 2 years of life","volume":"138","author":"Toivonen","year":"2016","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.026_b0235","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1128\/JCM.01646-13","article-title":"Simultaneous detection and differentiation of human rhino- and enteroviruses in clinical specimens by real-time PCR with locked nucleic acid probes","volume":"51","author":"Osterback","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.04.026_b0240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcv.2014.11.018","article-title":"Blood MxA protein as a marker for respiratory virus infections in young children","volume":"62","author":"Toivonen","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2019.04.026_b0245","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2015.07.294","article-title":"Performance of the alere i influenza A&B assay and mariPOC test for the rapid detection of influenza A and B viruses","volume":"70","author":"Jokela","year":"2015","journal-title":"J Clin Virol"},{"issue":"9930","key":"10.1016\/j.vaccine.2019.04.026_b0250","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(13)61682-7","article-title":"Use of vaccines as probes to define disease burden","volume":"383","author":"Feikin","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.026_b0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/mi.2015.35","article-title":"Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage","volume":"9","author":"Glennie","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.026_b0260","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/INF.0000000000000872","article-title":"Associations between viral and bacterial potential pathogens in the nasopharynx of children with and without respiratory symptoms","volume":"34","author":"Skevaki","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.026_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1287640","article-title":"Efficacy of 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in panamanian children - a randomized controlled trial","volume":"13","author":"Saez-Llorens","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.026_b0270","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vacc"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.026_b0275","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1164\/rccm.201205-0806OC","article-title":"Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease","volume":"186","author":"Mallia","year":"2012","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:14:09Z","timestamp":1777536849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19304773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":55,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19304773"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}